Bimekizumab
From WikiMD's Food, Medicine & Wellness Encyclopedia
Bimekizumab (INN[1]) is a monoclonal antibody that is being investigated for ankylosing spondylitis and psoriasis.
This drug is being developed by UCB. As of 2018[update], bimekizumab is undergoing Phase III trials.
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD